- Home
- RLAY vs AXGN Comparison
RLAY vs AXGN Comparison
Compare RLAY & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- AXGN
- Stock Information
- Founded
- RLAY 2015
- AXGN N/A
- Country
- RLAY United States
- AXGN United States
- Employees
- RLAY N/A
- AXGN N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- RLAY Health Care
- AXGN Health Care
- Exchange
- RLAY Nasdaq
- AXGN Nasdaq
- Market Cap
- RLAY 619.0M
- AXGN 577.0M
- IPO Year
- RLAY 2020
- AXGN N/A
- Fundamental
- Price
- RLAY $3.99
- AXGN $16.41
- Analyst Decision
- RLAY Strong Buy
- AXGN Strong Buy
- Analyst Count
- RLAY 13
- AXGN 5
- Target Price
- RLAY $18.00
- AXGN $26.00
- AVG Volume (30 Days)
- RLAY 1.2M
- AXGN 1.2M
- Earning Date
- RLAY 11-05-2025
- AXGN 11-06-2025
- Dividend Yield
- RLAY N/A
- AXGN N/A
- EPS Growth
- RLAY N/A
- AXGN N/A
- EPS
- RLAY N/A
- AXGN N/A
- Revenue
- RLAY $8,355,000.00
- AXGN $203,271,000.00
- Revenue This Year
- RLAY $31.55
- AXGN $19.65
- Revenue Next Year
- RLAY N/A
- AXGN $15.84
- P/E Ratio
- RLAY N/A
- AXGN N/A
- Revenue Growth
- RLAY N/A
- AXGN 17.17
- 52 Week Low
- RLAY $1.78
- AXGN $9.22
- 52 Week High
- RLAY $8.32
- AXGN $21.00
- Technical
- Relative Strength Index (RSI)
- RLAY 58.70
- AXGN 60.88
- Support Level
- RLAY $3.87
- AXGN $15.88
- Resistance Level
- RLAY $4.20
- AXGN $17.00
- Average True Range (ATR)
- RLAY 0.21
- AXGN 0.69
- MACD
- RLAY 0.03
- AXGN -0.05
- Stochastic Oscillator
- RLAY 66.87
- AXGN 82.44
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.